VIRUS TODAY: 1 million cases in 5 days, FDA meets on vaccine

A Food and Drug Administration panel is meeting to decide whether to endorse the Pfizer vaccine

APTOPIX Virus Outbreak Pennsylvania
APTOPIX Virus Outbreak Pennsylvania

Here's what's happening Thursday with the coronavirus pandemic in the U.S.:

THREE THINGS TO KNOW TODAY

— A Food and Drug Administration panel is meeting to decide whether to endorse the Pfizer vaccine. What normally would be a dull scientific event has attracted a massive following as the world anxiously awaits word on a vaccine.

— The U.S. recorded more than 3,000 new COVID-19 deaths Wednesday as hospitals sink deeper into crisis. That exceeds the number of Americans who died on Sept. 11 and D-Day.

— With the virus surging and new restrictions taking effect nationwide, more Americans are applying for unemployment. The 853,000 people who sought jobless benefits last week was the most since September.

THE NUMBERS: More than 1 million people have tested positive for the virus in the last five days. The U.S. is averaging 2,279 deaths per day.

QUOTABLE: "No one asked for this pandemic. I am trying to play the cards I am dealt with, and I have a really bad hand.” - Montrell McGraw, an out-of-work restaurant employee in New Orleans.

IN CASE YOU MISSED IT: As the virus tears through the country, plenty of people are still commuting to work, on trains, buses and cars. The commute has become an anxiety-ridden ordeal for many of them.

ON THE HORIZON: The FDA has to sign off on the recommendation from the panel discussing the Pfizer drug.

___

Find AP’s full coverage of the coronavirus pandemic at https://apnews.com/hub/coronavirus-pandemic

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in